Clinical Trials | Phase I/II Study of DFP-10917 in Combination with Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia

The University of Virginia is participating in a clinical research study for adults ages 18 and over, who have have AML that is resistant to or has returned following previous anti-leukemia treatment. This study is designed to investigate whether DFP 10917 given in combination with venetoclax will be an effective and safe treatment option for patients with AML. You may continue to receive multiple treatment cycles as long as you are tolerating the treatment and your doctor determines that you are benefiting from the treatment. You will also have some of these tests and procedures performed within 28 days after you stop taking the study treatment. The study team will contact you approximately every 6 months following the end of your study treatment. Study-related procedures that are being done beyond your standard of care will be provided at no cost to you or your insurance. Additional information can be found here: https://clinicaltrials.gov/study/NCT06382168 [email protected] The (department, division name) seeks (insert as applies: adults/men/women/adolescents/children) ages (insert) with (insert condition) for a research study. The purpose of the study is (insert purpose of study - eg.to test the effectiveness of an investigational medicine; or to find out how stress effects blood pressure.) (Optional)You may be eligible for this study if: (insert brief eligibility criteria 3 or 4 top criteria and in lay language. Do not copy eligibility criteria from the protocol) Study involves (insert procedures-examples: taking an experimental medicine/placebo, blood draws, x rays, overnight stays,) (Insert x number of visits every x (weeks, months,) each visit lasting x amount of time or give range). Insert one of the following: Study-related (insert exams, tests and experimental medication) provided at no cost. or Participant’s insurance company will be billed for medication, test,s and procedures